Patents by Inventor Paul D. Gamlin

Paul D. Gamlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified AAV capsid proteins and uses thereof
    Patent number: 11767346
    Abstract: Adeno associated viral (AAV) particles are emerging as a useful vehicle for gene delivery to various organs and tissues, one of them being the retina. Provided here are variant AAV (for example, variant serotype 2 (AAV2)) capsid proteins and variant capsid protein containing particles with enhanced ability to transduce retinal cells.
    Type: Grant
    Filed: March 8, 2022
    Date of Patent: September 26, 2023
    Assignees: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Sergei Zolotukhin, Sanford L. Boye, Shannon E. Boye, Damien Marsic, Paul D. Gamlin
  • MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
    Publication number: 20220267383
    Abstract: Adeno associated viral (AAV) particles are emerging as a useful vehicle for gene delivery to various organs and tissues, one of them being the retina. Provided here are variant AAV (e.g., variant serotype 2 (AAV2)) capsid proteins and variant capsid protein containing particles with enhanced ability to transduce retinal cells.
    Type: Application
    Filed: March 8, 2022
    Publication date: August 25, 2022
    Applicants: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Sergei Zolotukhin, Sanford L. Boye, Shannon E. Boye, Damien Marsic, Paul D. Gamlin
  • Modified AAV capsid proteins and uses thereof
    Patent number: 11332502
    Abstract: Adeno associated viral (AAV) particles are emerging as a useful vehicle for gene delivery to various organs and tissues, one of them being the retina. Provided here are variant AAV (e.g., variant serotype 2 (AAV2)) capsid proteins and variant capsid protein containing particles with enhanced ability to transduce retinal cells.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: May 17, 2022
    Assignees: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Sergei Zolotukhin, Sanford L. Boye, Shannon E. Boye, Damien Marsic, Nicholas Muzyczka, Hector Ruben Mendez-Gomez, Paul D. Gamlin
  • METHODOLOGY FOR IDENTIFYING GENE DELIVERY VECTORS WITH RETINAL CELL SPECIFICITY IN NON-HUMAN PRIMATE
    Publication number: 20200330611
    Abstract: The present application provides methods of producing sortable sub-populations of retinal cells. Methods can be used in vivo. Methods can be used to produce sortable sub- populations of cells in non-human primate retina. Methods can be used in conjunction with vivo testing of gene therapy agents and ex-vivo cell sorting and analysis to determine the specificity and/or effectiveness of transgene transduction, transcription, expression, and/or function of the transgene product.
    Type: Application
    Filed: February 16, 2017
    Publication date: October 22, 2020
    Applicants: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Shannon E. Boye, Sanford L. Boye, Paul D. Gamlin
  • Modified AAV capsid proteins and uses thereof
    Patent number: 10793606
    Abstract: Adeno associated viral (AAV) particles are emerging as useful vehicle for gene delivery to various organs and tissues, one of them being the retina. Provided here are variant AAV (e.g., variant serotype 2 (AAV2)) capsid proteins and variant capsid protein containing particles with enhanced ability to transduce retinal cells.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: October 6, 2020
    Assignees: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Sergei Zolotukhin, Sanford L. Boye, Shannon E. Boye, Damien Marsic, Paul D. Gamlin
  • MODIFIED AAV CAPSID PROTEINS AND USES THEREOF
    Publication number: 20200002386
    Abstract: Adeno associated viral (AAV) particles are emerging as useful vehicle for gene delivery to various organs and tissues, one of them being the retina. Provided here are variant AAV (e.g., variant serotype 2 (AAV2)) capsid proteins and variant capsid protein containing particles with enhanced ability to transduce retinal cells.
    Type: Application
    Filed: August 21, 2019
    Publication date: January 2, 2020
    Applicants: University of Florida Research Foundation, Incorporated, The UAB Research Foundation
    Inventors: Sergei Zolotukhin, Sanford L. Boye, Shannon E. Boye, Damien Marsic, Nicholas Muzyczka, Hector Ruben Mendez-Gomez, Paul D. Gamlin